on VALNEVA (EPA:VLA)
Valneva announces the publication of its financial results for the first quarter of 2026
Valneva SE, a vaccine specialist, announced that it will release its consolidated financial results for the first quarter of 2026 on May 13. The company will hold a web conference at 3:00 p.m. CET to discuss these results and provide an update on its business. This web conference will be available live and on-demand on the company's website.
Valneva develops, produces, and markets vaccines against infectious diseases requiring medical solutions. It has a Lyme disease vaccine candidate in partnership with Pfizer, and other projects in development. With three travel vaccines already on the market, it continues to expand its portfolio.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALNEVA news